131 related articles for article (PubMed ID: 12857040)
1. Medical progress in idiopathic myelofibrosis.
Okamura T
Intern Med; 2003 Jun; 42(6):461-2. PubMed ID: 12857040
[No Abstract] [Full Text] [Related]
2. Constitutional trisomy 8 mosaicism in primary myelofibrosis: relevance to clinical practice and warning for trisomy 8 studies.
Maserati E; Pressato B; Valli R; Patitucci F; Lo Curto F; Pasquali F; Minelli A; Danesino C; Marchetti M; Barosi G
Cancer Genet Cytogenet; 2007 Nov; 179(1):79-81. PubMed ID: 17981220
[No Abstract] [Full Text] [Related]
3. Trisomy 13 is associated with poor prognosis in idiopathic myelofibrosis with myeloid metaplasia.
Zojer N; Meran JG; Vesely M; Grüner H; Ackermann J; Dellinger C; Zimmer-Roth I; Heinz R; Drach J; Ludwig H
Leuk Lymphoma; 1999 Oct; 35(3-4):415-21. PubMed ID: 10706468
[TBL] [Abstract][Full Text] [Related]
4. Prognosis and survivorship in primary myelofibrosis.
Reilly JT
Am J Hematol; 2010 Jan; 85(1):4-5. PubMed ID: 20029947
[No Abstract] [Full Text] [Related]
5. Cytogenetic and molecular genetic aspects of idiopathic myelofibrosis.
Reilly JT
Acta Haematol; 2002; 108(3):113-9. PubMed ID: 12373082
[TBL] [Abstract][Full Text] [Related]
6. Cytogenetics of bone marrow fibroblastic cells in idiopathic chronic myelofibrosis.
Greenberg BR; Woo L; Veomett IC; Payne CM; Ahmann FR
Br J Haematol; 1987 Aug; 66(4):487-90. PubMed ID: 3663505
[TBL] [Abstract][Full Text] [Related]
7. Circulating CD34(+) cells as prognostic and follow-up marker in patients with myelofibrosis undergoing allo-SCT.
Alchalby H; Lioznov M; Fritzsche-Friedland U; Badbaran A; Zabelina T; Bacher U; Stübig T; Ayuk FA; Zander AR; Kröger N
Bone Marrow Transplant; 2012 Jan; 47(1):143-5. PubMed ID: 21358677
[No Abstract] [Full Text] [Related]
8. Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosis.
Solé F; de Pablos JM; Woessner S; Pérez MM; Jurado M; Espinet B; Grao P; Moratalla A; Esquivias J
Cancer Genet Cytogenet; 1997 Apr; 94(2):147-50. PubMed ID: 9109946
[TBL] [Abstract][Full Text] [Related]
9. Advances in the therapy of chronic idiopathic myelofibrosis.
Arana-Yi C; Quintás-Cardama A; Giles F; Thomas D; Carrasco-Yalan A; Cortes J; Kantarjian H; Verstovsek S
Oncologist; 2006 Sep; 11(8):929-43. PubMed ID: 16951397
[TBL] [Abstract][Full Text] [Related]
10. Clinical and molecular genetic characterization of myelofibrosis.
Hobbs GS; Rampal RK
Curr Opin Hematol; 2015 Mar; 22(2):177-83. PubMed ID: 25635755
[TBL] [Abstract][Full Text] [Related]
11. Trisomy 13 in a patient with idiopathic myelofibrosis.
Gozzetti A; Crupi R; Tozzuoli D; Fabbri A; Bocchia M; Lauria F
Cancer Genet Cytogenet; 2005 Jan; 156(2):185. PubMed ID: 15642403
[No Abstract] [Full Text] [Related]
12. Long-term follow-up of a patient with idiopathic myelofibrosis associated with chromosome 11 and 13 abnormalities.
Toubai T; Tanaka J; Higa T; Ota S; Ibata M; Shono Y; Mashiko S; Miura Y; Umehara S; Kahata K; Toyoshima N; Morioka M; Asaka M; Kasai M; Imamura M
Am J Hematol; 2005 Jan; 78(1):67-70. PubMed ID: 15609290
[TBL] [Abstract][Full Text] [Related]
13. Clinical features and outcomes of patients with primary myelofibrosis in Japan: report of a 17-year nationwide survey by the Idiopathic Disorders of Hematopoietic Organs Research Committee of Japan.
Takenaka K; Shimoda K; Uchida N; Shimomura T; Nagafuji K; Kondo T; Shibayama H; Mori T; Usuki K; Azuma T; Tsutsumi Y; Tanaka J; Dairaku H; Matsuo K; Ozawa K; Kurokawa M; Arai S; Akashi K
Int J Hematol; 2017 Jan; 105(1):59-69. PubMed ID: 27761702
[TBL] [Abstract][Full Text] [Related]
14. The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
Hidaka T; Shide K; Shimoda H; Kameda T; Toyama K; Katayose K; Kubuki Y; Nagata K; Takenaka K; Akashi K; Okamura T; Niho Y; Mizoguchi H; Omine M; Ozawa K; Harada M; Shimoda K
Eur J Haematol; 2009 Oct; 83(4):328-33. PubMed ID: 19549278
[TBL] [Abstract][Full Text] [Related]
15. Myelodysplastic syndrome with myelofibrosis and basophilia: detection of trisomy 8 in basophils by fluorescence in-situ hybridization.
Ma SK; Chan JC; Wan TS; Chan AY; Chan LC
Leuk Lymphoma; 1998 Oct; 31(3-4):429-32. PubMed ID: 9869209
[TBL] [Abstract][Full Text] [Related]
16. Myelofibrosis in a child suffering from a hypereosinophilic syndrome with trisomy 8: response to corticotherapy.
Michel G; Thuret I; Capodano AM; Scheiner C; Guitard AM; Mozziconacci MJ; Fossat C; Perrimond H
Med Pediatr Oncol; 1991; 19(1):62-5. PubMed ID: 1990258
[TBL] [Abstract][Full Text] [Related]
17. Idiopathic myelofibrosis: pathogenesis to treatment.
Reilly JT
Hematol Oncol; 2006 Jun; 24(2):56-63. PubMed ID: 16477581
[TBL] [Abstract][Full Text] [Related]
18. Stem cell transplantation in primary myelofibrosis of childhood.
Mitton B; de Oliveira S; Pullarkat ST; Moore TB
J Pediatr Hematol Oncol; 2013 Apr; 35(3):e120-2. PubMed ID: 23511496
[TBL] [Abstract][Full Text] [Related]
19. Controversies and dilemmas in allogeneic transplantation for myelofibrosis.
Shanavas M; Gupta V
Best Pract Res Clin Haematol; 2014 Jun; 27(2):165-74. PubMed ID: 25189727
[TBL] [Abstract][Full Text] [Related]
20. Is allogeneic stem cell transplantation for myelofibrosis still indicated at the time of molecular markers and JAK inhibitors era?
Lestang E; Peterlin P; Le Bris Y; Dubruille V; Delaunay J; Godon C; Theisen O; Blin N; Mahe B; Gastinne T; Garnier A; Touzeau C; Voldoire M; Bene MC; Le Gouill S; Milpied N; Mohty M; Moreau P; Guillaume T; Chevallier P
Eur J Haematol; 2017 Jul; 99(1):60-69. PubMed ID: 28370306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
